Table 2 Clinical and vocal phonetic findings in studied cases
From: Vocal cordopathy consequent to bronchial asthma inhalation therapy
Group B, occasional user, no = 47 | Group A, habitual user, no = 65 | P value | |||
|---|---|---|---|---|---|
Clinical findings | Adult age (N = 55) | Children age (N = 10) | Adult age (N = 37) | Children age (N = 10) | |
Dysphonia | |||||
After 6 months | 7 (12.7%) | 3 (30%) | 3 (8.1%) | 0 | 0.382 |
End of study | 10 (18.2%) | 4 (40%) | 6 (16.2%) | 0 | |
Phonasthenialow-pitched sound | |||||
After 6 months | 3 (5.4%) | 3 (30%) | 6 (16.2%) | 0 | 0.655 |
End of study | 6 (10.9%) | 4 (40%) | 9 (24.3%) | 0 | |
Strained character | |||||
After 6 months | 5 (9%) | 2 (20%) | 4 (10.8%) | 0 | 0.730 |
End of study | 12 (21.8%) | 3 (30%) | 5 (13.5%) | 0 | |
Harsh cough | |||||
After 6 months | 25 (45.4%) | 6 (60%) | 20 (54%) | 6 (60%) | 0.045 |
End of study | 35 (63.6%) | 8 (80/%) | 28 (75.6%) | 9 (90%) | |
Soreness | |||||
After 6 months | 30 (54.5%) | 5 (50%) | 20 (54%) | 6 (60%) | 0.027 |
End of study | 33 (60%) | 7 (70%) | 26(70.3%) | 7 (70%) | |